Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shree PacetronixBOM:527005 +1.08%81 PEG Ratio is 0.55 as of Jul. 18, 2026, which is 10% above its 10-year median of 0.50. GuruFocus rates BOM:527005 with a GF Score™ of 81/100 and a GF Value™ of ₹163.33 (Modestly Undervalued). Among 209 Medical Devices & Instruments companies, Shree Pacetronix ranks better than 89% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Shree Pacetronix's PEG Ratio or its related term are showing as below:
BOM:527005'
s PEG Ratio Range Over the Past 10 Years
Min: 0.19 Med: 0.5 Max: 6.12
Current: 0.55
During the past 13 years, Shree Pacetronix's highest PEG Ratio was 6.12. The lowest was 0.19. And the median was 0.50.
BOM:527005's PEG Ratio is ranked better than 89% of 209
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs BOM:527005: 0.55
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Shree Pacetronix (BOM:527005) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Shree Pacetronix PEG Ratio Related Terms
Shree Pacetronix PEG Ratio Historical Data
* Premium members only.
The historical data trend for Shree Pacetronix's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:527005 vs ISRG, BDX, MDLN: PEG Ratio Comparison
For the Medical Instruments & Supplies subindustry, Shree Pacetronix's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shree Pacetronix PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shree Pacetronix's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Shree Pacetronix's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Shree Pacetronix (BOM:527005) has a PEG Ratio of 0.55 as of Jul. 18, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Shree Pacetronix and its competitors. This is 10% above median its historical median of 0.50. Over the past decade, Shree Pacetronix's PEG Ratio has ranged from 0.19 to 6.12. According to the industry distribution chart, Shree Pacetronix ranks #23 out of 209 companies in the Medical Devices & Instruments industry, placing it in the top 11%.
Is Shree Pacetronix's PEG Ratio too high?
Shree Pacetronix's current PEG Ratio of 0.55 is 10% above median its 10-year median of 0.50. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 6.12. The Medical Devices & Instruments industry median PEG Ratio is 2.05. Shree Pacetronix's value of 0.55 is 73.2% below this industry median. Based on the distribution chart, Shree Pacetronix ranks #23 out of 209 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shree Pacetronix has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shree Pacetronix's PEG Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shree Pacetronix ranks #23 out of 209 companies for PEG Ratio. This places Shree Pacetronix in the top 11% of its industry — outperforming the majority of peers. The industry median PEG Ratio is 2.05. Shree Pacetronix's value of 0.55 is 73.2% below this benchmark. Historically, Shree Pacetronix's own PEG Ratio has ranged from 0.19 to 6.12 over the past decade. While the company's 10-year median is 0.50 vs. the industry median of 2.05, Shree Pacetronix has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 2.05, based on 209 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shree Pacetronix's current PEG Ratio of 0.55 is 73.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Shree Pacetronix and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shree Pacetronix's current PEG Ratio is 0.55, which is 10% above median its own 10-year median of 0.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shree Pacetronix stock overvalued right now?
Based on GuruFocus' analysis, Shree Pacetronix (BOM:527005) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹163.33, compared to a current price of ₹144.75 — trading 11.4% below its estimated fair value. The current PEG Ratio is 0.55, which is 10% above median its 10-year median of 0.50 and 73.2% below the Medical Devices & Instruments industry median of 2.05. Shree Pacetronix's overall GF Score™ is 81/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Shree Pacetronix (BOM:527005), the current PEG Ratio is 0.55 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shree Pacetronix (BOM:527005) Overvalued in 2026?
Based on GuruFocus' analysis, Shree Pacetronix stock appears to be undervalued.
The current stock price of ₹144.75 is trading 11.4% below its estimated GF Value™ of ₹163.33.
GuruFocus considers Shree Pacetronix to be Modestly Undervalued.
Key valuation signals for BOM:527005:
PEG Ratio: 0.55 (10% above median its 10-year median of 0.50)
GF Value™: ₹163.33 vs. price of ₹144.75 (11.4% below fair value)
Industry Position: 73.2% below the Medical Devices & Instruments median (#23 of 209)
No single metric tells the full story. See the BOM:527005 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shree Pacetronix Ltd is engaged in the manufacturing of medical and surgical equipment and orthopedic appliances. It is in the business of manufacturing and selling Implantable Cardiac Pacemakers. Pacemakers are anti-bradycardia implantable devices intended for permanent ventricular or atrial pacing applications. The Company is engaged in only one segment i.e. Life Saving Devices. It sells its life-saving devices in India and internationally, of which the majority of revenue is generated from the sales made in India.
81GF Score
Get the complete analysis for BOM:527005
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:527005 has been successfully added to your 
